Soluble interleukin-2 receptor as an indicator of immunological disturbance found in silicosis patients

H. Hayashi, M. Maeda, S. Murakami, N. Kumagai, Y. Chen, T. Hatayama, M. Katoh, N. Miyahara, S. Yamamoto, Y. Yoshida, Y. Nishimura, M. Kusaka, W. Fujimoto, Takemi Otsuki

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Silicosis patients (SILs) possess not only respiratory disorders but also alterations in autoimmunity. To determine an early indicator of immunological disturbance in SILs, the role of serum-soluble interleukin (IL)-2 receptor (sIL-2R) was analyzed. Of ten SlLs, immunological clinical parameters such as immunoglobulin (Ig) G, complements, the titer of autoantibodies including anti-nuclear antibodies (ANA), anti-Scl-70 antibody (Ab) and anti-centromere (CM) Ab, and experimental indicators such as serum-soluble Fas, serum IL-2, CD25+ cells in CD4+ or CD8+ fractions, and sIL-2R were divided from respiratory parameters such as % vital capacity (%VC), percentage of forced expiratory volume in 1 second (FEV1.0%) and v25/Ht (liter/second/m(body height) by a correlation assay. Additionally, a stepwise regression test showed that sIL-2R was correlated with Ig G, ANA and anti-CM Ab. Furthermore, factor analysis revealed that sIL-2R contributed to the subpopulation of SILs with poorer immunological status in the absence of alterations in respiratory status. By defining healthy donors as 1, SILs as 2 and patients with systemic sclerosis as 3 for immunopathological progression status as metric variables, sIL2R and ANA showed a strong positive correlation. This suggests that sIL-2R is a good clinical indicator of immunological disturbance found in SILs without clinical manifestations of any disturbance in autoimmunity. Further analysis using a large-scale number of patients should be performed to confirm these findings.

Original languageEnglish
Pages (from-to)53-62
Number of pages10
JournalInternational Journal of Immunopathology and Pharmacology
Volume22
Issue number1
Publication statusPublished - Jan 2009
Externally publishedYes

Fingerprint

Silicosis
Interleukin-2 Receptors
Anti-Idiotypic Antibodies
Centromere
Autoimmunity
Immunoglobulin G
Serum
Body Height
Status Epilepticus
Systemic Scleroderma
Vital Capacity
Forced Expiratory Volume
Autoantibodies
Statistical Factor Analysis
Interleukin-2
Tissue Donors
Antibodies

Keywords

  • Autoimmune diseases
  • SIL-2R
  • Silicosis
  • Systemic sclerosis

ASJC Scopus subject areas

  • Pharmacology
  • Immunology
  • Immunology and Allergy

Cite this

Soluble interleukin-2 receptor as an indicator of immunological disturbance found in silicosis patients. / Hayashi, H.; Maeda, M.; Murakami, S.; Kumagai, N.; Chen, Y.; Hatayama, T.; Katoh, M.; Miyahara, N.; Yamamoto, S.; Yoshida, Y.; Nishimura, Y.; Kusaka, M.; Fujimoto, W.; Otsuki, Takemi.

In: International Journal of Immunopathology and Pharmacology, Vol. 22, No. 1, 01.2009, p. 53-62.

Research output: Contribution to journalArticle

Hayashi, H, Maeda, M, Murakami, S, Kumagai, N, Chen, Y, Hatayama, T, Katoh, M, Miyahara, N, Yamamoto, S, Yoshida, Y, Nishimura, Y, Kusaka, M, Fujimoto, W & Otsuki, T 2009, 'Soluble interleukin-2 receptor as an indicator of immunological disturbance found in silicosis patients', International Journal of Immunopathology and Pharmacology, vol. 22, no. 1, pp. 53-62.
Hayashi, H. ; Maeda, M. ; Murakami, S. ; Kumagai, N. ; Chen, Y. ; Hatayama, T. ; Katoh, M. ; Miyahara, N. ; Yamamoto, S. ; Yoshida, Y. ; Nishimura, Y. ; Kusaka, M. ; Fujimoto, W. ; Otsuki, Takemi. / Soluble interleukin-2 receptor as an indicator of immunological disturbance found in silicosis patients. In: International Journal of Immunopathology and Pharmacology. 2009 ; Vol. 22, No. 1. pp. 53-62.
@article{261cac083cd54e4aaa929cb1cdd648e4,
title = "Soluble interleukin-2 receptor as an indicator of immunological disturbance found in silicosis patients",
abstract = "Silicosis patients (SILs) possess not only respiratory disorders but also alterations in autoimmunity. To determine an early indicator of immunological disturbance in SILs, the role of serum-soluble interleukin (IL)-2 receptor (sIL-2R) was analyzed. Of ten SlLs, immunological clinical parameters such as immunoglobulin (Ig) G, complements, the titer of autoantibodies including anti-nuclear antibodies (ANA), anti-Scl-70 antibody (Ab) and anti-centromere (CM) Ab, and experimental indicators such as serum-soluble Fas, serum IL-2, CD25+ cells in CD4+ or CD8+ fractions, and sIL-2R were divided from respiratory parameters such as {\%} vital capacity ({\%}VC), percentage of forced expiratory volume in 1 second (FEV1.0{\%}) and v25/Ht (liter/second/m(body height) by a correlation assay. Additionally, a stepwise regression test showed that sIL-2R was correlated with Ig G, ANA and anti-CM Ab. Furthermore, factor analysis revealed that sIL-2R contributed to the subpopulation of SILs with poorer immunological status in the absence of alterations in respiratory status. By defining healthy donors as 1, SILs as 2 and patients with systemic sclerosis as 3 for immunopathological progression status as metric variables, sIL2R and ANA showed a strong positive correlation. This suggests that sIL-2R is a good clinical indicator of immunological disturbance found in SILs without clinical manifestations of any disturbance in autoimmunity. Further analysis using a large-scale number of patients should be performed to confirm these findings.",
keywords = "Autoimmune diseases, SIL-2R, Silicosis, Systemic sclerosis",
author = "H. Hayashi and M. Maeda and S. Murakami and N. Kumagai and Y. Chen and T. Hatayama and M. Katoh and N. Miyahara and S. Yamamoto and Y. Yoshida and Y. Nishimura and M. Kusaka and W. Fujimoto and Takemi Otsuki",
year = "2009",
month = "1",
language = "English",
volume = "22",
pages = "53--62",
journal = "International Journal of Immunopathology and Pharmacology",
issn = "0394-6320",
publisher = "Biomedical Research Press s.a.s.",
number = "1",

}

TY - JOUR

T1 - Soluble interleukin-2 receptor as an indicator of immunological disturbance found in silicosis patients

AU - Hayashi, H.

AU - Maeda, M.

AU - Murakami, S.

AU - Kumagai, N.

AU - Chen, Y.

AU - Hatayama, T.

AU - Katoh, M.

AU - Miyahara, N.

AU - Yamamoto, S.

AU - Yoshida, Y.

AU - Nishimura, Y.

AU - Kusaka, M.

AU - Fujimoto, W.

AU - Otsuki, Takemi

PY - 2009/1

Y1 - 2009/1

N2 - Silicosis patients (SILs) possess not only respiratory disorders but also alterations in autoimmunity. To determine an early indicator of immunological disturbance in SILs, the role of serum-soluble interleukin (IL)-2 receptor (sIL-2R) was analyzed. Of ten SlLs, immunological clinical parameters such as immunoglobulin (Ig) G, complements, the titer of autoantibodies including anti-nuclear antibodies (ANA), anti-Scl-70 antibody (Ab) and anti-centromere (CM) Ab, and experimental indicators such as serum-soluble Fas, serum IL-2, CD25+ cells in CD4+ or CD8+ fractions, and sIL-2R were divided from respiratory parameters such as % vital capacity (%VC), percentage of forced expiratory volume in 1 second (FEV1.0%) and v25/Ht (liter/second/m(body height) by a correlation assay. Additionally, a stepwise regression test showed that sIL-2R was correlated with Ig G, ANA and anti-CM Ab. Furthermore, factor analysis revealed that sIL-2R contributed to the subpopulation of SILs with poorer immunological status in the absence of alterations in respiratory status. By defining healthy donors as 1, SILs as 2 and patients with systemic sclerosis as 3 for immunopathological progression status as metric variables, sIL2R and ANA showed a strong positive correlation. This suggests that sIL-2R is a good clinical indicator of immunological disturbance found in SILs without clinical manifestations of any disturbance in autoimmunity. Further analysis using a large-scale number of patients should be performed to confirm these findings.

AB - Silicosis patients (SILs) possess not only respiratory disorders but also alterations in autoimmunity. To determine an early indicator of immunological disturbance in SILs, the role of serum-soluble interleukin (IL)-2 receptor (sIL-2R) was analyzed. Of ten SlLs, immunological clinical parameters such as immunoglobulin (Ig) G, complements, the titer of autoantibodies including anti-nuclear antibodies (ANA), anti-Scl-70 antibody (Ab) and anti-centromere (CM) Ab, and experimental indicators such as serum-soluble Fas, serum IL-2, CD25+ cells in CD4+ or CD8+ fractions, and sIL-2R were divided from respiratory parameters such as % vital capacity (%VC), percentage of forced expiratory volume in 1 second (FEV1.0%) and v25/Ht (liter/second/m(body height) by a correlation assay. Additionally, a stepwise regression test showed that sIL-2R was correlated with Ig G, ANA and anti-CM Ab. Furthermore, factor analysis revealed that sIL-2R contributed to the subpopulation of SILs with poorer immunological status in the absence of alterations in respiratory status. By defining healthy donors as 1, SILs as 2 and patients with systemic sclerosis as 3 for immunopathological progression status as metric variables, sIL2R and ANA showed a strong positive correlation. This suggests that sIL-2R is a good clinical indicator of immunological disturbance found in SILs without clinical manifestations of any disturbance in autoimmunity. Further analysis using a large-scale number of patients should be performed to confirm these findings.

KW - Autoimmune diseases

KW - SIL-2R

KW - Silicosis

KW - Systemic sclerosis

UR - http://www.scopus.com/inward/record.url?scp=62649093102&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62649093102&partnerID=8YFLogxK

M3 - Article

C2 - 19309552

AN - SCOPUS:62649093102

VL - 22

SP - 53

EP - 62

JO - International Journal of Immunopathology and Pharmacology

JF - International Journal of Immunopathology and Pharmacology

SN - 0394-6320

IS - 1

ER -